Diabetes, Vol 38, Issue 10 1211-1216, Copyright © 1989 by American Diabetes Association

ARTICLES

Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans

JP Palmer, S Helqvist, GA Spinas, J Molvig, T Mandrup-Poulsen, HU Andersen and J Nerup

This study was designed to test the hypothesis that target-cell activity influences the degree and time course of interleukin 1 beta (IL-1 beta)-mediated beta-cell impairment in vitro. Functional and morphological studies were performed in cultured newborn rat islets of Langerhans exposed from 6 h to 6 days to 50-2000 ng/L recombinant human IL-1 beta. Beta-Cell activity was modulated by glucose and nonglucose agents (15 mM L-leucine and 10 microM of long-acting somatostatin analogue SMS 201-995). In 11 mM glucose, 2000 ng/L of IL-1 beta caused inhibition of insulin release after approximately 6 h of exposure to IL-1 beta; in 3.3 mM glucose culture, onset of inhibition was delayed by this IL-1 beta concentration until after 48 h of exposure. Similarly, stimulation and suppression of beta-cell function with L-leucine and SMS 201-995, respectively, resulted in acceleration and delay of IL-1 beta-mediated inhibition. The dose-response curve of the IL-1 beta effect was shifted left- and rightward during high and low beta-cell activity, respectively. In analogy, increasing IL-1 beta concentration, exposure time, and beta-cell activity resulted in increasing islet disintegration. Thus, the resting beta-cell is more resistant to IL-1 beta-mediated impairment than the working beta-cell.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L Zhao, Z Li, M Kullin, L A H Borg, and F A Karlsson Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli J. Endocrinol., May 1, 2005; 185(2): 291 - 299. [Abstract] [Full Text] [PDF]

				N. R. Barshes, S. Wyllie, and J. A. Goss Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts J. Leukoc. Biol., May 1, 2005; 77(5): 587 - 597. [Abstract] [Full Text] [PDF]

				E. Ortqvist, E. Bjork, M. Wallensteen, J. Ludvigsson, J. Aman, C. Johansson, G. Forsander, F. Lindgren, L. Berglund, M. Bengtsson, et al. Temporary Preservation of {beta}-Cell Function by Diazoxide Treatment in Childhood Type 1 Diabetes Diabetes Care, September 1, 2004; 27(9): 2191 - 2197. [Abstract] [Full Text] [PDF]

				S. M. Weber, A. L. Scarim, and J. A. Corbett Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2 Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E883 - E891. [Abstract] [Full Text] [PDF]

				P. O. T. Tran, C. E. Gleason, and R. P. Robertson Inhibition of Interleukin-1{beta}-Induced COX-2 and EP3 Gene Expression by Sodium Salicylate Enhances Pancreatic Islet {beta}-Cell Function Diabetes, June 1, 2002; 51(6): 1772 - 1778. [Abstract] [Full Text] [PDF]

				L. C Stene, P. Magnus, R. T Lie, O. Søvik, G. Joner, and The Norwegian Childhood Diabetes Study Group Birth weight and childhood onset type 1 diabetes: population based cohort study BMJ, April 14, 2001; 322(7291): 889 - 892. [Abstract] [Full Text]

				M.-C. Chen, V. Paez-Espinosa, N. Welsh, and D. L. Eizirik Interleukin-1{beta} Regulates Phospholipase D-1 Expression in Rat Pancreatic {beta}-Cells Endocrinology, August 1, 2000; 141(8): 2822 - 2828. [Abstract] [Full Text] [PDF]

				P. O. T. Tran, C. E. Gleason, V. Poitout, and R. P. Robertson Prostaglandin E2 Mediates Inhibition of Insulin Secretion by Interleukin-1beta J. Biol. Chem., October 29, 1999; 274(44): 31245 - 31248. [Abstract] [Full Text] [PDF]

				A. L. Scarim, M. R. Heitmeier, and J. A. Corbett Heat Shock Inhibits Cytokine-Induced Nitric Oxide Synthase Expression by Rat and Human Islets Endocrinology, December 1, 1998; 139(12): 5050 - 5057. [Abstract] [Full Text] [PDF]

				A. L. Scarim, M. R. Heitmeier, and J. A. Corbett Irreversible Inhibition of Metabolic Function and Islet Destruction after a 36-Hour Exposure to Interleukin-1{beta} Endocrinology, December 1, 1997; 138(12): 5301 - 5307. [Abstract] [Full Text] [PDF]